Serial bioluminescence imaging every 4 days demonstrated that ZIKV- and anti–PD-1–treated tumors regressed at approximately day 18 after tumor implantation (11 days after virus treatment) (Figure 4, C and D). The gene discussed is PDCD1; the disease is neoplasm.